
    
      This study will be a phase 4 open label interventional case series. Patients with
      retinoblastoma will be receive chemotherapy with or without periocular injections of
      carboplatin at a dose of 20mg/2 ml. Patients will receive chemotherapy on a monthly basis for
      a total duration of therapy of 6 months. Patients will be followed for 18 months .
    
  